Vanda Pharmaceuticals (VNDA) Stock Analysis: AI Score & Alternative Data
VNDA alt-data: job postings climbing, business outlook lagging
Is Vanda Pharmaceuticals a buy right now? The alternative data says hold. This VNDA stock analysis is built on the 25+ alternative data signals AltIndex tracks on Vanda Pharmaceuticals every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 47/100: a Hold. The stock trades at $4.57 with a $274M market cap.
The bullish side of the 90-day ledger: job postings up 22.2% to 99 open roles, and headcount (according to LinkedIn) up 7.0% to 659 employees. The drag: business outlook fell 15.2% — now 56% of employees are positive, and web traffic down 9.9% to 16K monthly visits. That tension is what keeps the score mid-range.
VNDA’s broader alt-data profile also covers quarterly revenue ($50M), X followers (2K), and sentiment (96/100). Every signal links to its own page with full history, the VNDA technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on VNDA is just below.
Vanda Pharmaceuticals AI Stock Analysis
Vanda Pharmaceuticals Inc. is a biopharmaceutical company committed to the development and commercialization of innovative therapies for high unmet medical needs. Their portfolio includes treatments for schizophrenia, insomnia, jet lag disorder, and other central nervous system disorders.
Analysis generated October 3, 2026.
Recent Vanda Pharmaceuticals Stock Alerts
|
Vanda Pharmaceuticals | September 7 Business Outlook among employees is down by 8.2% over the last month. |
|
Vanda Pharmaceuticals | August 12 Price is up by 6.2% in the last 24h. |
|
Vanda Pharmaceuticals | August 10 Employee Rating is down by 2.7% over the last month. |
|
Vanda Pharmaceuticals | August 10 Business Outlook among employees is down by 7.6% over the last month. |
Vanda Pharmaceuticals Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 16K | 9.9% | |
| Job Posts | 99 | 22.2% | |
| LinkedIn Employees | 659 | 7.0% | |
| Employee Recommend | 57 | 8.1% | |
| Business Outlook | 56 | 15.2% | |
| Sentiment | 96 | 4.0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 12 | 1,100.0% | |
| Stocktwits Mentions | 59 | 34.1% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 5K | 0.6% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 2K | 1.5% |
About Vanda Pharmaceuticals (VNDA)
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
| Price | $4.57 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $274M |
| Year Range | $4 – $10 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Vanda Pharmaceuticals News
View more → |
Vanda Pharmaceuticals Announces Presentation at 2026 EADV Annual MeetingOctober 2 - PRNewswire |
 |
Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase DisorderSeptember 29 - PRNewswire |
 |
Vanda Pharmaceuticals Announces Participation at September 2026 Investor ConferencesSeptember 2 - PRNewswire |
 |
Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European CommissionAugust 24 - PRNewswire |
Vanda Pharmaceuticals Inc. Q2 2026 Earnings Call SummaryAugust 5 - Moby.co |
See Vanda Pharmaceuticals’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for VNDA, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEVanda Pharmaceuticals Earnings & Financial Performance
View all earnings →Vanda Pharmaceuticals Insider Trading Activity
View all →| Birznieks Gunther filed to sell 494,197 shares at $0.0. Mar 2 '26 |
| Williams Timothy filed to sell 377,450 shares at $0.0. Mar 2 '26 |
| Wijkstrom Joakim filed to sell 333,469 shares at $0.0. Mar 2 '26 |
| Moran Kevin Patrick filed to sell 411,380 shares at $0.0. Mar 2 '26 |
| Polymeropoulos Mihael Hristos filed to sell 2,704,496 shares at $0.0. Mar 2 '26 |
Vanda Pharmaceuticals Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Vanda Pharmaceuticals
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Inhibikase TherapeuticsIKT |
$1.97 3.1% | $275M | 47 |
 |
Larimar TherapeuticsLRMR |
$2.67 1.1% | $277M | 54 |
 |
Palisade BioPALI |
$1.54 6.2% | $268M | 48 |
 |
Century TherapeuticsIPSC |
$1.47 0.7% | $266M | 49 |
 |
2Seventy BioTSVT |
$4.99 0.0% | $266M | 44 |
Explore Vanda Pharmaceuticals Data
Frequently Asked Questions: Vanda Pharmaceuticals (VNDA)
Vanda Pharmaceuticals has an AltIndex AI Score of 47/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
47/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Vanda Pharmaceuticals (VNDA) stock is $4.57 with a market cap of $274M.
As of today, Vanda Pharmaceuticals’s PE (Price to Earnings) ratio is —.
View the latest Vanda Pharmaceuticals insider transactions to see recent buying and selling activity by company executives and directors.
Check the Vanda Pharmaceuticals congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The VNDA stock price chart above shows Vanda Pharmaceuticals’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Vanda Pharmaceuticals technical analysis for RSI, moving averages, and more.
See the stocks similar to Vanda Pharmaceuticals section on this page for companies in the same industry ranked by market cap and AI Score.
